Developer of a breath-based diabetes monitor. The Lassie breath analyzer is a non-invasive device for measuring critical biomarkers from exhaled breath and detects glucose levels. This device also detects and monitors other diseases such as cancer, obesity, asthma, and more. Operating in the Life Sciences > Diabetes, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology sector. with business models spanning Wearable Technology > Health and Wellness Devices > Diabetes Monitoring, Disease Self Management > Diabetes > Monitoring > Glucose > Device. Founded in 2015, headquartered in Toulouse, France. The company has raised $7.5M at the Series A stage, backed by investors including EIC Fund, Diabetes Venture Fund, BioSerenity, Europa, Jolt Capital.
BOYDSense
Series ADeveloper of a breath-based diabetes monitor. The Lassie breath analyzer is a non-invasive device for measuring critical biomarkers from exhaled breath and detects glucose levels. This device also detects and monitors other diseases such as cancer, obesity, asthma, and more. Operating in the Life Sciences > Diabetes, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology…
About
Business model
Wearable Technology > Health and Wellness Devices > Diabetes Monitoring,
Disease Self Management > Diabetes > Monitoring > Glucose > Device,
Diabetes > Medical Devices > Monitoring Devices > CGM > Non-Invasive
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.